Nearly 50% of testicular cancer risk passed down genetically, new study reports

NewsGuard 100/100 Score

Almost half of the risk of developing testicular cancer comes from the DNA passed down from our parents, a new study reports.

The research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20 per cent of risk.

The findings suggest testing for a range of genetic variants linked to testicular cancer could be effective in picking out patients who are at substantially increased risk - potentially opening up ways of preventing the disease.

Scientists at The Institute of Cancer Research, London, along with colleagues in Germany, Sweden and the US, used two independent approaches to analyse the risk of testicular germ cell tumours - easily the most common type of testicular cancer.

Their research, published in the journal Scientific Reports and funded by the Movember Foundation, The Institute of Cancer Research (ICR) and Cancer Research UK, is the largest study ever to explore testicular germ cell tumours in detail.

Researchers first used statistical analysis to examine patterns of ancestral testicular cancer in family groups across 15.7 million people from the Swedish Population Registry cancer family database, including 9,324 cases of testicular cancer.

They then looked in detail at the genetic code of 6,000 UK men from two previous testicular cancer studies, 986 of whom had been diagnosed with the disease.

The combined analysis revealed that 49 per cent of all the possible factors contributing to testicular cancer risk are inherited.

It found that the inherited risk comes from a large number of minor variations in DNA code, rather than one faulty gene with a big effect.

Although substantial inroads have been made over the last five years at the ICR into identifying mutations associated with risk of testicular cancer, the study also showed that these known mutations only account for 9.1 per cent of the risk of developing the disease. Therefore the majority of the genetic variants that raise testicular cancer risk have yet to be identified.

Identifying more of these 'hidden' mutations could allow doctors to screen men for testicular cancer risk, increasing the chance of preventing the disease or catching it early.

Dr Clare Turnbull, Senior Researcher in Genetics and Epidemiology at The Institute of Cancer Research, London, said:

"Our study has shown that testicular cancer is a strongly heritable disease. Around half of a man's risk of developing testicular cancer comes from the genes he inherits from his parents - with environmental and behavioural factors contributing to the other half.

"Our findings have important implications in that they show that if we can discover these genetic causes, screening of men with a family history of testicular cancer could help to diagnose those at greatest risk, and help them to manage that risk.

"But our study also shows that much work remains to be done. There are a lot of genetic factors that cause testicular cancer which we are yet to find - so the first step must be to identify the genetic drivers of testicular cancer so we can develop new ways to prevent it."

Sam Gledhill, the Movember Foundation's Global Manager for Testicular Cancer Programmes, said:

"This is a significant development in the fight for a world where no man dies of testicular cancer. Dr Turnbull and her team at the ICR have generated important evidence to demonstrate that genetic factors might in the future help identify men and boys who have a higher risk of developing testicular cancer. These discoveries help to unlock the mysteries of this relatively poorly understood cancer and may ultimately identify potential treatment targets to fight this disease.

"The Movember Foundation and the ICR have shared a valuable partnership to date and we are delighted to confirm that we will continue to support this work from the proceeds of the 2015 Movember campaign. To help us to continue to support world-changing research, like that of Dr Turnbull and her team, we encourage you to support the 2015 Movember campaign by visiting http://www.movember.com."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New cancer projections show increased prostate cases by 25% in 2050, despite prevention efforts